CPMEA Welcomes Federal Budget Measures to Strengthen Canadian Manufacturing and Economic Security

PRESS RELEASE

November 16, 2026, Toronto, ON – The Canadian Pharmaceutical Manufacturers and Exporters Alliance (CPMEA) welcomes the Government of Canada's Budget 2026 measures to strengthen domestic investment, productivity and economic resilience.
CPMEA commends the government for the Productivity Mega Deduction, enhancements to the Scientific Research and Experimental Development (SR&ED) program, and additional funding for the Strategic Response Fund. These initiatives represent important steps toward encouraging investment in Canadian manufacturing and supporting the commercialization of Canadian research and development.
CPMEA has consistently advocated for a more competitive tax and investment environment, including enhanced SR&ED incentives and targeted measures to support pharmaceutical development, technology transfer and domestic production.
We also welcome the government's recognition of the importance of strengthening Canada's defence industrial base and national security. As CPMEA has emphasized, a strong domestic pharmaceutical manufacturing sector is essential to ensuring reliable access to medicines during emergencies, international conflicts and global supply chain disruptions.
CPMEA looks forward to working with the government to build on these commitments, strengthen Canada's pharmaceutical manufacturing capacity and advance a more secure, self-sufficient Canadian medicine supply.
About the Canadian Pharmaceutical Manufacturers and Exporters Alliance
The Canadian Pharmaceutical Manufacturers and Exporters Alliance represents Canadian-based pharmaceutical manufacturers dedicated to producing high-quality prescription medicines for patients in Canada and around the world. Our members invest in Canadian manufacturing facilities, support highly skilled jobs, strengthen domestic supply chains, and contribute to Canada's health and economic security.
For more information please contact:
Terry Creighton
416 904 1711



